unr.edu

Human Papillomavirus (HPV) High Risk, NAAT

Specimen Container Vial with PreservCyt® solution, ThinPrep® or SurePath-recommended container; ThinPrep specimens must be tranferred to an Aptima Specimen tube within 105 days of collection. SurePath ...
Nasdaq

BD Onclarity™ HPV Assay Receives FDA Approval for Use with Both BD SurePath™ Liquid-based Pap Test and Hologic ThinPrep® Pap Test

FRANKLIN LAKES, N.J., Feb. 21, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) ...
unr.edu

PAP Smear, ThinPrep® Method

Label container with patient's first name, last name and DOB Indicate specimen source on requisition slip Include birth date, LMP, last PAP smear, exogenous hormones, drug therapy and any previous ...
Nasdaq

BD Submits PMA Supplement To FDA For ThinPrep Pap Test PreservCyt Solution Vial - Quick Facts

(RTTNews) - Medical technology company Becton, Dickinson and Co. or BD (BDX) announced Wednesday that it has submitted a pre-market approval (PMA) supplement to the U.S. Food and Drug Administration ...
Business Insider

BD Submits Pre-Market Approval Supplement to FDA to Enable ThinPrep® Pap Test™ PreservCyt® Solution to be Used with the BD Onclarity™ HPV Assay

FRANKLIN LAKES, N.J., Sept. 23, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has submitted a pre-market ...